Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis

被引:0
|
作者
Bastos, Mayara Lisboa [1 ,2 ,3 ]
Oxlade, Olivia [3 ]
Campbell, Jonathon R. [2 ,3 ]
Faerstein, Eduardo [1 ]
Menzies, Dick [2 ,3 ]
Trajman, Anete [1 ,3 ,4 ,5 ]
机构
[1] Univ Estado Rio De Janeiro, Social Med Inst, Rio De Janeiro, Brazil
[2] McGill Univ, Ctr Outcomes Res & Evaluat, Resp Epidemiol & Clin Res Unit, Res Inst,Hlth Ctr, Montreal, PQ, Canada
[3] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada
[4] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil
[5] Rua Macedo Sobrinho 74-203, BR-22271080 Rio De Janeiro, Brazil
来源
基金
加拿大健康研究院;
关键词
Brazil; Tuberculosis; Latent tuberculosis; Cascade-of-care; cost-effectiveness; budget impact; tuberculosis preventive therapy;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background In Brazil, investigation and treatment of tuberculosis infection (TBI) in households contacts (HHC) of TB patients is not a priority. We estimated the cost-effectiveness and budget-impact of scaling-up an enhanced HHC management in Brazil.Methods We conceptualized a cascade-of-care that captures how HHC of tuberculosis patients are investigated in Brazil (status quo) and two enhanced strategies for management of HHC focusing on: (1) only tuberculosis disease (TBD) detection and, (2) TBD and TBI detection and treatment. Effectiveness was the number of HHC diagnosed with TBD and completing TBI treatment. Proportions in the cascades-of-care were derived from a meta-analysis. Health-system costs (2019 US$) were based on literature and official data from Brazil. The impact of enhanced strat-egies was extrapolated using reported data from 2019.Findings With the status quo, 0 (95% uncertainty interval: 0-1) HHC are diagnosed with TBD and 2 (0-16) complete TBI treatment. With strategy(1), an additional 15 (3-45) HHC would be diagnosed with TBD at a cost of US$346 each. With strategy(2), 81 (19-226) additional HHC would complete TBI treatment at a cost of US$84 each. A com-bined strategy, implemented nationally to enhance TBD detection and TBI treatment would result in an additional 9,711 (845-28,693) TBD being detected, and 51,277 (12,028-143,495) more HHC completing TBI treatment each year, utilizing 10.9% and 11.6% of the annual national tuberculosis program budget, respectively. Interpretation Enhanced detection and treatment of TBD and TBI among HHC in Brazil can be achieved at a national level using current tools at reasonable cost.Copyright (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) The 2022;8:
引用
收藏
页数:12
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF BETA BLOCKERS FOR CHRONIC HEART FAILURE PATIENTS IN SPAIN
    Espallardo, O.
    Polanco, C.
    VALUE IN HEALTH, 2009, 12 (07) : A323 - A323
  • [32] Cost-effectiveness analysis and budgetary impact of anidulafungin treatment for patients with candidemia and other forms of invasive candidiasis in Brazil
    Vianna, Cid Manso de Mello
    Mosegui, Gabriela Bittencourt Gonzalez
    Rodrigues, Marcus Paulo da Silva
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2023, 65
  • [33] FERRIC CARBOXYMALTOSE IN THE TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE FROM THE PERSPECTIVE OF PRIVATE HEALTH CARE SYSTEM: COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT IN BRAZIL
    Campagnaro, M.
    Picoli, R. M.
    Castelano, N.
    Clemente, V
    Serna, Ramirez de Arellano A.
    VALUE IN HEALTH, 2023, 26 (12) : S111 - S111
  • [34] Cost-Effectiveness Analysis of Somatostatin Analogues in the Treatment of Acromegaly in Brazil
    Valentim, Joice
    Passos, Vanessa
    Mataveli, Fabio
    Calabro, Alessandra
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (09) : 1452 - 1460
  • [35] Treatment for human visceral leishmaniasis: a cost-effectiveness analysis for Brazil
    Silva Ferreira de Carvalho, Isis Polianna
    Peixoto, Henry Maia
    Sierra Romero, Gustavo Adolfo
    Fernandes de Oliveira, Maria Regina
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2019, 24 (09) : 1064 - 1077
  • [36] Therapies for treatment of osteoporosis in US women: Cost-effectiveness and budget impact considerations
    Tosteson, Anna N. A.
    Burge, Russel T.
    Marshall, Deborah A.
    Lindsay, Robert
    AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (09): : 605 - 615
  • [37] THE COST-EFFECTIVENESS AND BUDGET IMPACT OF ITOPRIDE HYDROCHLORIDE FOR THE TREATMENT OF FUNCTIONAL DYSPEPSIA IN VIETNAM
    Kim, K.
    Kim, H.
    Byrnes, J.
    Bian, A. R.
    Thu, Nguyen Thi C.
    VALUE IN HEALTH, 2023, 26 (06) : S144 - S145
  • [38] Fluoroquinolone Therapy for the Prevention of Multidrug-Resistant Tuberculosis in Contacts A Cost-Effectiveness Analysis
    Fox, Gregory J.
    Oxlade, Olivia
    Menzies, Dick
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (02) : 229 - 237
  • [39] COST-EFFECTIVENESS OF ALTERNATIVE STRATEGIES FOR TUBERCULOSIS HOUSEHOLD CONTACT INVESTIGATION IN RURAL AND URBAN SOUTH AFRICA
    Young, N.
    Biche, P.
    Mohlamonyane, M.
    Morolo, M.
    Maholwana, B.
    Ahmed, K.
    Martinson, N.
    Hanrahan, C. F.
    Dowdy, D. W.
    VALUE IN HEALTH, 2024, 27 (12) : S79 - S79
  • [40] Cost-effectiveness analysis of dasatinib for the treatment of imatinib resistant or intolerant CML patients in Brazil
    Quissak, C.
    Litalien, G.
    Alves, M. R.
    VALUE IN HEALTH, 2008, 11 (03) : A64 - A64